Therapeutic sequences in patients with grade 1 −2 neuroendocrine tumors (NET): an observational multicenter study from the ELIOS group

ConclusionsSSA followed by SSA high dose, everolimus, chemotherapy or PRRT represent the main therapeutic sequences in G1 −G2 NET. Median PFS was not significantly different between sequences. However, the sequences with SSA high dose or PRRT seem to be better tolerated than sequences with everolimus or chemotherapy.

Source: Endocrine - March 13, 2019 Category: Endocrinology Source Type: research